Abstract

Drug nanosuspensions/nanocrystals have been recognized as one useful and successful approach for drug delivery. Drug nanocrystals could be further decorated to possess extended functions (such as controlled release) and designed for special in vivo applications (such as drug tracking), which make best use of the advantages of drug nanocrystals. A lot of novel and advanced size reduction methods have been invented recently for special drug deliveries. In addition, some novel downstream processes have been combined with nanosuspensions, which have highly broadened its application areas (such as targeting) besides traditional routes. A large number of recent research publication regarding as nanocrystals focuses on above mentioned aspects, which have widely attracted attention. This review will focus on the recent development of nanocrystals and give an overview of regarding modification of nanocrystal by some new approaches for tailor-made drug delivery.

Highlights

  • Drug nanosuspensions, often referred to as drug nanocrystals, can be considered as one of the most successful pharmaceutical nanotechnology approach

  • An increasing number of novel advanced preparation methods and downstream technologies have been developed for tailor-made drug delivery

  • The Wet bead milling (WBM) led to the smallest particle size of 88 nm as well the highest final drug release, tablets produced applying nanocrystals obtained from high pressure homogenization (HPH) and the two step approach could achieve faster dissolution rates within the first 20 min than WBM (Liu et al, 2018)

Read more

Summary

Introduction

Often referred to as drug nanocrystals, can be considered as one of the most successful pharmaceutical nanotechnology approach. Some novel technologies have been invented recently, which possessed the capability to produce smaller nanoparticle sizes

Ultra-small particle size for fast drug release
Special instrument design
Physical modification of drug before top-down
Ultra-small scale for initial research stage
Reduced crystallinity of drug nanocrystals by using bottom-up
Reduced crystallinity of drug nanocrystals by using downstream
Carrier-free (stabilizer-based) nanocrystals
Nanocrystals loaded in carrier
Nanocrystals loaded in carriers for oral
Nanocrystals loaded in carriers for inhalation
Nanocrystals loaded in carriers for transdermal
Nanocrystals loaded in cell for targeting
Printing nanosuspension for personalized medicines
Hybrid nanocrystals for drug tracking
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.